Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.16%
#2 0G 0G +29.67%
#3 Nockchain Nockchain +23.93%
#4 Zora Zora +23.55%
#5 Fake World Assets Fake World Assets +19.22%
#6 Full Moon Full Moon +17.70%
#7 Axelar Axelar +17.49%
#8 Notcoin Notcoin +16.89%
#9 ADO Protocol ADO Protocol +15.48%
#10 SAFEcoin SAFEcoin +13.35%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Settings
Language
ENGLISH
Currency
USD
Theme
Lionco Pharmaceutical Group Co.,Ltd. Lionco Pharmaceutical Group Co.,Ltd.

Lionco Pharmaceutical Group Co.,Ltd.

603669
Rank in Stocks #12772
Lionco Pharmaceutical Group Co., Ltd., in collaboration with its various... Lionco Pharmaceutical Group Co., Ltd., in collaboration with its various subsidiaries, actively participates in the entire lifecycle of pharmaceutical products within China, from initial research and development to manufacturing and sales. The company boasts a comprehensive portfolio of therapeutic solutions, encompassing medications for nutritional support, antimicrobial and antiviral treatments, digestive disorders, cardiovascular health, detoxification, and anti-tumor therapies, alongside other specialized products. Furthermore, it maintains dedicated research institutes that focus specifically on the advancement of chemical, natural, and biological drugs. Established in 2003, Lionco Pharmaceutical Group Co., Ltd. is headquartered in Shannan, China.
Share Price
$0.77384014
Market Cap
$551.23M
Change (1 day)
-2.73%
Change (1 year)
-11.00%
Country
CN
Trade Lionco Pharmaceutical Group Co.,Ltd. (603669)

Category

Healthcare
Revenue for Lionco Pharmaceutical Group Co.,Ltd. (603669)
Revenue in Aug 2026 TTM: 0
According to Lionco Pharmaceutical Group Co.,Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Lionco Pharmaceutical Group Co.,Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH